| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | ||
|---|---|---|---|---|---|---|
Revenue | ||||||
182,626 | 139,021 | 101,369 | 70,010 | 48,687 | ||
Cost of revenue | ||||||
51,870 | 43,080 | 37,190 | 30,004 | 21,890 | ||
Gross profit | ||||||
130,756 | 95,941 | 64,179 | 40,006 | 26,797 | ||
Operating expenses: | ||||||
Sales and marketing | ||||||
71,825 | 56,460 | 46,345 | 30,922 | 20,957 | ||
Research and development | ||||||
35,810 | 30,316 | 23,057 | 16,167 | 10,517 | ||
General and administrative | ||||||
37,471 | 30,497 | 29,530 | 18,422 | 10,730 | ||
Change in fair value of contingent consideration | ||||||
0 | 0 | -11 | -1,434 | 428 | ||
Total operating expenses | ||||||
145,106 | 117,273 | 98,921 | 64,077 | 42,632 | ||
Loss from operations | ||||||
-14,350 | -21,332 | -34,742 | -24,071 | -15,835 | ||
Change in fair value of preferred stock warrant | ||||||
0 | 0 | 25 | 283 | 302 | ||
Interest income | ||||||
109 | -1,123 | -943 | -68 | - | ||
Interest Expense | ||||||
- | - | - | - | 21 | ||
Other income (expense), net | ||||||
-384 | -203 | -132 | -68 | -26 | ||
Loss before provision for income taxes | ||||||
-14,625 | -22,658 | -35,842 | -24,490 | -16,184 | ||
Income tax provision (benefit) | ||||||
167 | 321 | 246 | 116 | 63 | ||
Net loss | ||||||
-14,792 | -22,979 | -36,088 | -24,606 | -16,247 | ||
Accretion of redeemable convertible preferred stock | ||||||
0 | 0 | 9,862 | 21,311 | 27,892 | ||
Deemed dividendpreferred stock modification | ||||||
0 | 0 | -1,748 | 0 | - | ||
Net loss attributable to common stockholders | ||||||
-14,792 | -22,979 | -44,202 | -45,917 | -44,139 | ||
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | ||||||
-0.33 | -0.58 | -1.68 | -4.17 | -4.10 | ||
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted (in shares) | ||||||
44,309 | 39,913 | 26,320 | 11,013 | 10,757 | ||